A) Inflammability B) Toxicity C) Biocompatibility D) Corrosiveness
A) To prevent regeneration B) To induce inflammation C) To block cell growth D) To provide a structure for cells to grow and organize
A) Fatigue resistance B) Thermal conductivity C) Chemical stability D) Biodegradability
A) High cost B) Heavy weight C) Biocompatibility D) Corrosion
A) Increase toxicity B) Reduce mechanical strength C) Enhanced surface interactions and properties D) Decrease biocompatibility
A) PMMA B) Hydroxyapatite C) Silicone rubber D) Polyethylene
A) Macrophages B) Red blood cells C) Fibroblasts D) Keratinocytes
A) To increase toxicity B) To promote inflammation C) To accelerate degradation D) To prevent infections
A) Astrophysics B) Biomaterials science or biomaterials engineering C) Quantum mechanics D) Marine biology
A) There is no difference between them B) Biomaterials cannot be used in medical applications C) Biological materials are always synthetic D) Biomaterials are engineered, while biological materials are naturally produced
A) Exclusively organic compounds B) Pure water-based solutions C) Metallic components, polymers, ceramics, or composite materials D) Only natural fibers
A) By computational routines predicting molecular effects based on limited in vitro experimentation B) Using only historical data without new testing C) Through random trial and error methods D) Exclusively through animal testing
A) A process requiring mechanical manipulation to form structures. B) The spontaneous aggregation of particles without external forces. C) The random distribution of particles in a solution. D) An assembly method that uses magnetic fields.
A) The spatial scale of the unit cell (lattice parameter). B) The chemical composition of particles. C) The temperature at which assembly occurs. D) The external forces applied to the system.
A) Chemical bonding between particles. B) External guidance and control. C) Random particle distribution. D) Self-organization.
A) 70 to 100 nm. B) 3 nm. C) 60 nm. D) 1.5 nm.
A) About 60/40. B) 70/30. C) 50/50. D) 80/20.
A) Within the mineral phase only. B) At the gaps between collagen fibrils. C) Randomly throughout the matrix. D) On the surface of tropocollagen molecules.
A) "Bricks" with dimensions of 0.5. B) 20 to 30 nm layers. C) 1 μm diameter rods. D) 60 nm diameter canals.
A) Chitin. B) Collagen. C) Calcium carbonate. D) Hydroxyapatite.
A) A cubic pattern. B) A helical pattern. C) An amorphous structure. D) A random distribution.
A) 70 to 100 nm. B) 60 nm. C) 20 to 30 nm. D) 1 μm.
A) ISO 27001 B) ISO 9001 C) ISO 10993 D) ISO 14001
A) Amino acids B) Sugars C) Nucleotides D) Fatty acids
A) Dental filling material B) Artificial skin scaffold C) Bone graft substitute D) Heart valve coating
A) Stainless steel B) Pyrolytic carbon C) Polyethylene terephthalate D) Calcium sulfate
A) Animal skin B) Metal wires C) Synthetic polymers D) Plant fibers
A) 10 different configurations B) 5 different configurations C) 14 different configurations D) 20 different configurations
A) Kevlar B) Spandex C) Dacron D) Nylon
A) Healing process B) Inflammatory reaction C) Foreign body response (FBR) D) Immune response
A) Sub atomic level B) Molecular level C) Microstructure level D) Ultra-structure level
A) 25% B) 49% C) 75% D) 60%
A) Non-biodegradable B) Mechanically strong C) Electrically conductive D) Chemically reactive
A) 1 μm. B) 3 nm. C) 60 nm. D) 20 to 30 nm.
A) 3 mm. B) 1.5 nm. C) 70 to 100 nm. D) Approximately 60 nm.
A) Biodegradation B) Biocompatibility C) Biofabrication D) Biomimetics
A) 1980s B) Later 1960s C) 2000s D) Early 1950s
A) Drug delivery B) Tissue growth stimulation C) Wound closure D) Bone strengthening
A) Chronic phase B) Acute phase C) Healing phase D) Resolution phase
A) Brittle B) Toxic C) Non-degradable D) Biocompatible
A) Alignment B) Elasticity C) Size D) Shape
A) Liposomes B) Silica C) Polyetheretherketone (PEEK) D) Polymers
A) Starch B) Proteins C) DNA D) Cellulose
A) Eosinophils B) Macrophages C) Neutrophils D) Lymphocytes
A) Foreign body response B) Acute inflammation only C) Graft-versus-host disease D) Biocompatibility
A) Dental implants B) Skin repair devices C) Contact lenses D) Joint replacements
A) Immune cells B) Only the damaged tissue C) No structures are isolated D) The implant
A) DNA B) Silk C) Starch D) Cellulose
A) Biodegradable B) Non-biodegradable C) Toxic D) Inert
A) Tensile strength B) Young's Modulus C) Flexural rigidity D) Ductility
A) Cyclic olefin polymer (COP) B) Polyetherimide (PEI) C) Polycarbonate (PC) D) Polypropylene (PP)
A) Avoid any interaction with the immune system B) Elicit a strong immune reaction C) Direct the immune response rather than circumvent it D) Suppress the immune response entirely
A) Flexural rigidity B) Compressive strength C) Toughness D) Elasticity
A) Stainless steel B) Ivory C) Aluminum D) Ceramic
A) Mass Spectrometry B) Scanning Electron Microscopy C) X-ray Diffraction D) Nuclear Magnetic Resonance
A) Edge dislocation B) Line defects C) Macrostructure D) Point defects |